Avricore Appoints New CEO, Hector Bremner Resigns
PorAinvest
viernes, 6 de junio de 2025, 6:56 am ET1 min de lectura
AVGR--
David Hall, Chairman of the board, expressed excitement about Seccombe taking the helm as CEO, stating, "In his role as Avricore’s CTO, Rodger has been instrumental in the development of the Company’s flagship HealthTab platform. We are excited to have Rodger take the helm as CEO of Avricore as its UK expansion initiative gathers steam" [1].
Hector Bremner, who achieved many milestones for Avricore, including its growth with Shoppers Drug Mart and expansion into the UK, has resigned from his position as CEO and director of the company. The company has expressed gratitude for Bremner's experience and expertise, looking forward to future collaborations [1, 2, 3].
HealthTab offers a unique network model that empowers pharmacists and patients, reducing costs and waiting times while providing multiple revenue streams [3]. The platform generates lab-accurate results in real-time, using just a few drops of blood from a finger prick. It includes tests for chronic diseases like diabetes and heart disease, as well as bacterial and viral tests such as strep and COVID-19 [3].
Avricore Health Inc. is focused on advancing pharmacy practice and patient care through early-stage technology acquisitions and development. The company's mission is to make actionable health information more accessible by creating the world's largest network of rapid testing devices in community pharmacies [3].
References:
[1] https://finance.yahoo.com/news/avricore-appoints-rodger-seccombe-ceo-110000428.html
[2] https://www.marketscreener.com/quote/stock/AVRICORE-HEALTH-INC-49477269/news/Avricore-Health-Inc-Announces-CEO-Changes-Changes-50167657/
[3] https://www.stockwatch.com/News/Item/Z-C!AVCR-3696927/C/AVCR
AVRE--
Avricore has appointed Rodger Seccombe as CEO, replacing Hector Bremner who resigned from the position. Seccombe currently serves as the company's Chief Technology Officer and President and Co-Founder of its subsidiary, HealthTab. He will continue to oversee HealthTab in his new role as CEO.
Avricore Health Inc. (TSXV: AVCR) has appointed Rodger Seccombe as its new CEO, replacing Hector Bremner who resigned from the position. Seccombe currently serves as the company's Chief Technology Officer and President and Co-Founder of its subsidiary, HealthTab Inc. In his new role as CEO, Seccombe will continue to oversee HealthTab, which is a turnkey point-of-care testing solution combining best-in-class point-of-care technologies with a secure, cloud-based platform [1].David Hall, Chairman of the board, expressed excitement about Seccombe taking the helm as CEO, stating, "In his role as Avricore’s CTO, Rodger has been instrumental in the development of the Company’s flagship HealthTab platform. We are excited to have Rodger take the helm as CEO of Avricore as its UK expansion initiative gathers steam" [1].
Hector Bremner, who achieved many milestones for Avricore, including its growth with Shoppers Drug Mart and expansion into the UK, has resigned from his position as CEO and director of the company. The company has expressed gratitude for Bremner's experience and expertise, looking forward to future collaborations [1, 2, 3].
HealthTab offers a unique network model that empowers pharmacists and patients, reducing costs and waiting times while providing multiple revenue streams [3]. The platform generates lab-accurate results in real-time, using just a few drops of blood from a finger prick. It includes tests for chronic diseases like diabetes and heart disease, as well as bacterial and viral tests such as strep and COVID-19 [3].
Avricore Health Inc. is focused on advancing pharmacy practice and patient care through early-stage technology acquisitions and development. The company's mission is to make actionable health information more accessible by creating the world's largest network of rapid testing devices in community pharmacies [3].
References:
[1] https://finance.yahoo.com/news/avricore-appoints-rodger-seccombe-ceo-110000428.html
[2] https://www.marketscreener.com/quote/stock/AVRICORE-HEALTH-INC-49477269/news/Avricore-Health-Inc-Announces-CEO-Changes-Changes-50167657/
[3] https://www.stockwatch.com/News/Item/Z-C!AVCR-3696927/C/AVCR

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios